CIK: 0001825034 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $736,724 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 896,254 | $525,277 | 71.3% | $485.48 | — | TR UNIT | 78462F103 |
| INDA | ISHARES TR | 2,425,144 | $127,660 | 17.3% | $42.12 | — | MSCI INDIA ETF | 46429B598 |
| VEU | VANGUARD INTL EQUITY INDEX F | 1,013,434 | $58,181 | 7.9% | $60.21 | — | ALLWRLD EX US | 922042775 |
| ORIC | ORIC PHARMACEUTICALS INC | 989,410 | $7,985 | 1.1% | $23.68 | -61.3% | COM | 68622P109 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,573,761 | $7,428 | 1.0% | $16.74 | -56.5% | COM | 344174107 |
| PMVP | PMV PHARMACEUTICALS INC | 2,627,643 | $3,968 | 0.5% | $35.52 | -95.5% | COM | 69353Y103 |
| ALEC | ALECTOR INC | 1,307,858 | $2,472 | 0.3% | $10.94 | -65.6% | COM | 014442107 |
| TNYA | TENAYA THERAPEUTICS INC | 1,015,705 | $1,452 | 0.2% | $19.78 | -88.7% | COM | 87990A106 |
| SRZN | SURROZEN INC | 87,696 | $1,258 | 0.2% | $6.97 | +52.2% | COM NEW | 86889P208 |
| — | RAPT THERAPEUTICS INC | 657,899 | $1,039 | 0.1% | $19.12 | — | COM | 75382E109 |
| SRZNW | SURROZEN INC | 170,833 | $4 | 0.0% | $0.04 | — | *W EXP 08/01/203 | 86889P117 |